Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Eaton Corporation plc (ETN) vs Heron Therapeutics Inc (HRTX) Price & Performance

Eaton Corporation plcTrade
Heron Therapeutics IncTrade

Price performance (Past 24H)

Key statistics

Eaton Corporation plc vs Heron Therapeutics Inc — how do they compare? Eaton Corporation plc trades at $464.45 (market cap $172.82B), while Heron Therapeutics Inc trades at $0.34 (market cap $61.47M). The key difference: Eaton Corporation plc is far larger — about 2811.5× Heron Therapeutics Inc's market cap, and Eaton Corporation plc pays a 0.99% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.

ETNHRTX
Market Cap
$172.82B$61.47M
Sector
TechnologyHealth
52-Week High
$459.29$1.49
52-Week Low
$315.82$0.32
Enterprise Value
$193.45B$168.21M
Dividend Yield
0.99%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Eaton Corporation plc

Eaton Corporation (ETN) trades at $468.37, up 5.26% in 24 hours, reflecting strong momentum after recent earnings beats. The stock exhibits a bullish technical trend with support at $456 and resistance at $470. Q2 2026 earnings beat expectations with EPS of $3.15 versus $3.07 estimated, and the company raised its full-year outlook, driven by robust demand in electrical and data center segments.

Outlook remains positive given raised guidance and AI-driven power infrastructure demand, but risks include premium valuation (P/E 45.31) and execution challenges. Analyst consensus is bullish with a $499.75 price target, though investors should monitor competitive pressures and macroeconomic conditions affecting industrial spending.

Heron Therapeutics Inc

HRTX trades at $0.3152, down 4.54% today, amid bearish technical signals and mixed earnings. The stock shows a high gross margin of 70.07% but negative net income margins, with Q2 2026 missing revenue and EPS estimates. Recent news highlights patent litigation developments and quarterly results falling short of expectations, contributing to investor caution.

The outlook remains challenged by persistent losses and operational cash burn, though analyst consensus is strongly bullish with 94.74% buy ratings. Key risks include execution on product sales, competitive pressures, and reliance on financing activities to sustain operations amid negative profitability.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Eaton Corporation plc

Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.

Read more on ETN

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX